Does polycystic ovary syndrome start in childhood?

Pediatric Endocrinology Reviews

Volumn 5, Issue 4, 2008, Pages 904-911

  Diamanti Kandarakis, Evanthia ^a   Christakou, Charikleia ^a   Palioura, Eleni ^a   Kandaraki, Eleni ^a   Livadas, Sarantis ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Adolescence; Cardiovascular risk; Hyperandrogenemia; Insulin resistance; Obesity; Polycystic Ovary Syndrome; Premature adrenarche

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIANDROGEN; ANTICONVULSIVE AGENT; CONTRACEPTIVE AGENT; FLUTAMIDE; GONADORELIN DERIVATIVE; INSULIN; INSULIN SENSITIZING AGENT; LUTEINIZING HORMONE; METFORMIN; ORAL CONTRACEPTIVE AGENT;

ACNE; ANDROGEN SYNTHESIS; ANOVULATION; ARTICLE; CHILD; DIAGNOSTIC APPROACH ROUTE; DISEASE COURSE; DRUG MEGADOSE; ECHOGRAPHY; ENVIRONMENTAL FACTOR; HIRSUTISM; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LONG TERM CARE; MENSTRUATION DISORDER; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PATHOPHYSIOLOGY; PHYSICAL ACTIVITY; PHYSICAL EXAMINATION; PRENATAL EXPOSURE; PREVALENCE; ADOLESCENT; FEMALE; ONSET AGE; PHYSIOLOGY; PUBERTY; REVIEW;

ADOLESCENT; AGE OF ONSET; CHILD; FEMALE; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; PUBERTY;

EID: 49049109938     PISSN: 15654753     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. Diamanti-Kandarakis E, Kouli C, Bergiele A, Filandra FA., Tsianateli TC, Spina GG, Zapanti ED, Bartzis MI. A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile. J Clin Endocrinol Metab 1999;84(11):4006-4011
2. Hashemipour M, Faghihimani S, Zolfaghary B, Hovsepian S, Ahmadi F, Haghighi S. Prevalence of Polycystic Ovary Syndrome in GirLs Aged 14-18 Years in Isfahan, Iran. Horm Res 2004;62(6):278-282
3. Zawadski JK, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Polycystic Ovary Syndrome. Dunaif A, Givens JR, Haseltine FP, Merriam GE (Eds), (Series Ed: Hershman, SM). Current Issues in Endocrinology and Metabolism, Blackwell Scientific Publications, Boston 1992 p.377
4. The Rotterdam ESHRE/ASRM-sponsored Consensus Workshop Group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 2004;81(1):19-25
5. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE, Witchel SF. Androgen Excess Society Position Statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab 2006;91(11):4237-4245
6. Diamanti-Kandarakis E, Panidis D. Unraveling the phenotypic map of polycystic ovary syndrome (PCOS): a prospective study of 634 women with PCOS. Clin Endocrinol (Oxf) 2007;67(5):735-742
7. Diamanti-Kandarakis E, Piperi C. Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth. Hum Reprod Update 2005;11(6):631-643
8. Diamanti-Kandarakis E. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications. Exp Rev Mol Med 2008;10:e3
9. Diamanti-Kandarakis E, Papavassiliou AG. Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends Mol Med 2006;12(7):324-332
10. Abbott DH, Barnett DK, Bruns CM, Dumesic DA Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome? Hum Reprod Update 2005;11(4):357-374
11. Sir-Petermann T, Aumesic DA, Lara HE, Pérez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod 2002;17(10):2573-2579
12. Ibanez L, Lopez-Bermejo A, Callejo J, Torres A, Cabre S, Dunger D, de Zegher F. Polycystic Ovaries in Nonobese Adolescents and Young Women with Ovarian Androgen Excess:Relation to Prenatal Growth. J Clin Endocrinol Metab 2008;93:196-199
13. Carlsen S, Jacobsen G, Romundstad P. Maternal testosterone levels during pregnancy are associated with offspring size at birth. Eur J Endocrinol 2006;155(2):365-370
14. Sir-Petermann T, Hitchsfeld C, Maliqueo M., Codner E, Echiburu B, Gazitua R, Recabarren S, Cassorla F. Birth weight in offspring of mothers with polycystic ovarian syndrome. Human Reproduction 2005;20:2122-2126
15. Ibanez L, de Zegher F, Francois I, Potau N. Precocious pubarche,hyperinsulinism and ovarian hyperandrogenism in girls: relation to reduced fetal growth. J Clin Endocrinol Metab 1998;83:3558-3662
16. Ibanez L, Valls C, Potau N, Marcos M, de Zegher F. Polycystic Ovary syndrome after precocious pubarche: ontogeny of the low birth weight effect.Clin Endocrinol 2001;55:667-672
17. Rosenfield RL. Clinical review: Identifying Children at Risk for Polycystic Ovarian Syndrome. J Clin Endocrinol Metab 2007;92(3):787-796
18. Ibanez L, DiMartino-Nardi J, Potau N, Saenger P. Premature adrenarche -normal variant or forerunner of adult disease? Endocr Rev 2000;21:671-696
19. Ibañez L, Potau N, Virdis R, Zampolli M, Terzi C, Gussinyé M, Carrascosa A, Vicens-Calvet E. Postpubertal outcome in girls diagnosed of premature pubarche during childhood: increased frequency of functional ovarian hyperandrogenism. J Clin Endocrinol Metab 1993;76(6):1599-1603
20. Diamanti-Kandarakis E, Christakou C, Kandarakis H. Polycystic ovarian syndrome: the commonest cause of hyperandrogenemia in women as a risk factor for metabolic syndrome. Minerva Endocrinol 2007;32(1):35-44
21. Coviello A, Legro R, Dunaif A. Adolescent Girls with Polycystic Ovary Syndrome Have an Increased Risk of the Metabolic Syndrome Associated with Increasing Androgen Levels Independent of Obesity and Insulin Resistance J Clin Endocrinol Metab 2006;91:492-497
22. Diamanti-Kandarakis E, Christakou C, Kandarakis H, Alexandraki KI. Early onset adiposity: a pathway to polycystic ovary syndrome in adolescents? Hormones (Athens) 2007;6(3):210-217
23. McCartney C, Prendergast K, Eagleson CA, Yoo R, Chang RJ, Foster CM, Marshall JC. The Association of Obesity and Hyperandrogenemia during the Pubertal Transition in Girls: Obesity as a Potential Factor in the Genesis of Postpubertal Hyperandrogenism. J Clin Endocrinol Metab 2006;91(5):1714-1722
24. Mitchell M, Armstrong D, Robker R, Norman R. Adipokines: implications for female fertility and obesity. Reproduction 2005;130(5):583-597 Review
25. Sultan C, Paris F. Clinical expression of polycystic ovary syndrome in adolescent girls. Fertil Steril 2006;86(Suppl 1):S6
26. Peppard HR, Marfori J, Nestler JE. Prevalence of Polycystic Ovary Syndrome Among Premenopausal Women With Type 2 Diabetes.Diab Care 2001;24(1):1050 1052
27. Codner E, Escobar Morreale N. Clinical Review: Hyperandrogenism and Polycystic Ovary Syndrome (PCOS) in Women with Type 1 Diabetes Mellitus. J Clin Endocrinol Metab 2007;92(4):1209-1216
28. Mikkonen K, Vainionpää L, Pakarinen A, Knip M, Järvelä I, Tapanainen J, Isojärvi J. Long-term reproductive endocrine health in young women with epilepsy during puberty. Neurology 2004;10;62(3):445-450
29. Kahsar-Miller MD, Nixon C, Go RC, Azziz R. Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertil Steril 2001;75(1):53-58
30. Battaglia C, Regnani G, Mancini F, Iughetti L, Flamigni C, Venturoli S. Polycystic ovaries in childhood: a common finding in daughters of PCOS patients. A pilot study. Hum Reprod 2002;17(3):771-776
31. Sir-Petermann T, Maliqueo M, Codner E, Echiburú B, Crisosto N, Pérez V, Pérez-Bravo F, Cassorla F. Early metabolic derangements in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92(12):4637-4642
32. American Association of Clinical Endocrinologists Medical Guidelines for clinical practice for the diagnosis and treatment of hyperandrogenic disorders. Hyperandrogenic Disorders Task Force March/April 2001 Endocr Pract 2001;7(2):120-134
33. American Academy of Pediatrics, Committee on Adolescence, American College of Obstetricians and Gynecologists and Committee on Adolescent Health Care. Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign. Pediatrics 2006;118;2245-2250
34. Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. Glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92(12):4546-4556
35. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis S, Chrousos G. Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 2007;18(7):280-285 Review
36. OvariaHomburg R, Lambalk CB. Insulin Resistance and Polycystic. Polycystic ovary syndrome in adolescence - a therapeutic conundrum. Hum Reprod 2004;19(5):1039-1042
37. Diamanti-Kandarakis E, Nestler J, Panidis D, Pasquali R ed. n Syndrome Humana Press 2007
38. De Leo V, Musacchio MC, Morgante G, Petraglia F. Metformin treatment is effective in obese teenage girls with PCOS. Hum Reprod 2006;21(9):2252-2256
39. Ibáñez L, Ferrer A, Ong K, Amin R, Dunger D, de Zegher F. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome. J Pediatr 2004; 144(1):23-29
40. Ibáñez L, Valls C, Marcos MV, Ong K, Dunger DB, De Zegher F. Insulin sensitization for girls with precocious pubarche and with risk for polycystic ovary syndrome: effects of prepubertal initiation and postpubertal discontinuation of metformin treatment. J Clin Endocrinol Metab 2004;89(9):4331-4337
41. Diamanti Kandarakis E, Baillargeon JP, Iuorno M, Nestler JE. A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills. J Clin Endocrinol Metab 2003;88(5):1927-1932
42. Ibanez L, de Zegher F. Low-dose flutamide-metformin therapy for hyperinsulinemic hyperandrogenism in non-obese adolescents and women.Hum Reprod Update 2006;12:243-252